Molina Healthcare stock faces October results after profit drop

Published on 09/29/2026 at 08:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Molina Healthcare stock heads toward October 21 results after second quarter revenue fell 4.8 percent year over year. Analysts set a USD 202.44 consensus target.

Moderner Klinikcampus mit Glasfassade und Gesundheitspersonal vor Skyline — Fotorealistisches Bild zeigt Molina Healthcare US60855R1005 als modernen Klinikcampus mit Personal und Skyline im Hintergrund, Illustration mit AI erstellt.

Molina Healthcare stock (ISIN US60855R1005) was last at USD 189.64 on the NYSE on September 28, 2026, at 4:00 p.m. ET, down USD 1.22 or 0.64 percent from the prior close. The next earnings report is scheduled for October 21, giving investors a dated test for a business that posted a sharp year over year profit decline in the second quarter.

Second quarter profit fell

According to Business Wire in its September 2, 2026 release, Molina reported USD 10.874 billion in total revenue for Q2 2026, down 4.8 percent from USD 11.427 billion in Q2 2025. GAAP diluted EPS fell to USD 1.19 from USD 4.75, while adjusted diluted EPS reached USD 1.51 against a USD 1.39 consensus estimate.

GAAP net income was USD 60 million in Q2 2026, compared with USD 255 million a year earlier, according to the same company release. The comparison makes utilization, membership trends and medical cost control central to the October report rather than revenue alone.

Consensus target stays above price

MarketBeat reported a Hold consensus based on 17 analyst ratings as of September 28, 2026, with an average twelve-month target of USD 202.44. That target is USD 12.80 above the September 28 price, a gap of 6.75 percent, so the market price remains below the published analyst midpoint while the rating itself stays neutral.

Recent opinion remains divided. MarketBeat said Wall Street Zen upgraded Molina from Sell to Hold on September 26, 2026, while the same report listed price targets ranging from USD 124.00 to USD 286.00. The wide spread underscores the sensitivity of valuation to the company's earnings recovery.

October report sets next marker

According to Business Wire, Molina will release results for the quarter ending September 30, 2026, after the market closes on October 21, 2026, followed by a conference call on October 22 at 8:00 a.m. ET. That report will show whether the USD 1.51 adjusted EPS result from Q2 was a floor or a temporary improvement.

Stock remains below yearly high

Molina Healthcare was last at USD 189.64 on the NYSE on September 28, 2026, with a 52-week range of USD 121.06 to USD 244.89, market capitalization of USD 9.9 billion and volume of 553,754 shares. For investors, the key contrast is clear: the stock sits 22.56 percent below its yearly high while the consensus target is 6.75 percent above the latest price.